
Analysts Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $42.50
Neurogene Inc. (NASDAQ: NGNE - Get Free Report) has received a consensus rating of "Moderate Buy" from the six brokerages that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year


















